Ben Tre Pharmaceutical JSC

Ben Tre Pharmaceutical JSC Gross Margin

The Gross Margin of Ben Tre Pharmaceutical JSC (DBT.VN) as of Nov 20, 2026 is 39.84 %. In the previous year, Gross Margin was 38.15 % — a change of 4.44% (higher).

Gross Margin

39.84 %

YoY

4.44%

Last updated:

Gross Margin of Ben Tre Pharmaceutical JSC is 2024 39.84 % . Gross Margin of Ben Tre Pharmaceutical JSC was 2023 38.15 % . It decreases by 4.44% higher compared to the previous year.

Ben Tre Pharmaceutical JSC's gross margin stands at 39.8%, up from 25.3% several years earlier.

The Ben Tre Pharmaceutical JSC Gross Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Gross Margin
Date
Gross Margin
Jan 1, 2013
0.25 VND
Jan 1, 2014
22.78 VND
Jan 1, 2015
22.91 VND
Jan 1, 2020
25.31 VND
Jan 1, 2021
30.20 VND
Jan 1, 2022
33.28 VND
Jan 1, 2023
38.15 VND
Jan 1, 2024
39.84 VND
The Ben Tre Pharmaceutical JSC Gross Margin history
YEARGross MarginYoY
39.84 %+4.44%
38.15 %+14.61%
33.28 %+10.22%
30.20 %+19.33%
25.31 %+10.47%
22.91 %+0.58%
22.78 %+9,152.19%
0.25 %+19.22%
0.21 %+1.36%
0.20 %-4.03%
0.21 %+3.74%
0.20 %-5.90%
0.22 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Ben Tre Pharmaceutical JSC Stock analysis

What does Ben Tre Pharmaceutical JSC do? Ben Tre Pharmaceutical JSC manufactures and distributes pharmaceutical products, including medicinal products through its subsidiaries. The company wholesales, imports, and exports pharmaceuticals, materials, chemicals, packagings, and biological products. It also retails drugs and trades supplements, medical equipment, supplies, and machinery. The firm rents commercial space for additional revenue. Its primary customers are healthcare providers, pharmacies, and medical institutions requiring pharmaceuticals and medical supplies. The company's revenue streams include pharmaceutical manufacturing, wholesale distribution, import/export services, retail drug sales, and commercial space rentals. Key segments are pharmaceuticals, medical equipment, and biological products. The firm serves healthcare sectors through its subsidiaries and direct retail channels. Revenue is generated from both domestic and international trade activities. Ben Tre Pharmaceutical JSC's products include pharmaceuticals, medicinal products, medical equipment, and supplements. The company's brands are not specified in the business description. It targets healthcare providers, pharmacies, and medical institutions as its main buyers. The firm's operations span manufacturing, distribution, retail, and commercial leasing within the pharmaceutical and medical sectors. Ben Tre Pharmaceutical JSC is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Ben Tre Pharmaceutical JSC stock

Gross Margin of Ben Tre Pharmaceutical JSC is 39.84 % in 2024.

Gross Margin of Ben Tre Pharmaceutical JSC changed from 38.15 % to 39.84 %, representing a 4.44% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Gross Margin Ben Tre Pharmaceutical JSC since 2006 – with annual values, charts, and detailed analysis.

Gross Margin measures the percentage of revenue remaining after COGS. Higher gross margins indicate more efficient production and stronger pricing power.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Gross Margin's Ben Tre Pharmaceutical JSC with sector peers and the industry average to assess whether it is attractive.

To evaluate Gross Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Gross Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Ben Tre Pharmaceutical JSC

All Key Metrics — Ben Tre Pharmaceutical JSC